Name | Number of supported studies | Average coverage | |
---|---|---|---|
luminal cell of prostate epithelium | 4 studies | 84% ± 4% |
Insufficient scRNA-seq data for expression of KLK3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 426983.29 | 245 / 245 | 100% | 14538.17 | 502 / 502 |
thymus | 98% | 106.58 | 643 / 653 | 9% | 1.17 | 54 / 605 |
kidney | 89% | 50.38 | 79 / 89 | 10% | 1.19 | 94 / 901 |
adrenal gland | 75% | 54.68 | 194 / 258 | 10% | 7.81 | 23 / 230 |
intestine | 70% | 162.46 | 680 / 966 | 6% | 0.56 | 32 / 527 |
breast | 61% | 755.93 | 278 / 459 | 5% | 1.18 | 51 / 1118 |
uterus | 59% | 62.15 | 101 / 170 | 5% | 1.50 | 22 / 459 |
pancreas | 53% | 35.82 | 173 / 328 | 11% | 1.94 | 20 / 178 |
bladder | 57% | 40.33 | 12 / 21 | 5% | 2.64 | 24 / 504 |
liver | 49% | 20.67 | 111 / 226 | 5% | 0.76 | 21 / 406 |
ovary | 49% | 26.78 | 89 / 180 | 0% | 0 | 0 / 430 |
stomach | 48% | 21.90 | 171 / 359 | 1% | 0.30 | 4 / 286 |
skin | 40% | 28.23 | 730 / 1809 | 3% | 0.84 | 15 / 472 |
esophagus | 41% | 25.07 | 599 / 1445 | 1% | 0.07 | 2 / 183 |
spleen | 41% | 18.61 | 100 / 241 | 0% | 0 | 0 / 0 |
lung | 36% | 18.61 | 209 / 578 | 1% | 0.10 | 7 / 1155 |
heart | 30% | 19.79 | 259 / 861 | 0% | 0 | 0 / 0 |
adipose | 29% | 35.11 | 355 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 29% | 157.07 | 387 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 28% | 12.73 | 263 / 929 | 0% | 0 | 0 / 0 |
brain | 24% | 11.77 | 634 / 2642 | 4% | 0.57 | 28 / 705 |
muscle | 24% | 17.84 | 190 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 2.53 | 5 / 29 |
eye | 0% | 0 | 0 / 0 | 6% | 0.79 | 5 / 80 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.09 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002803 | Biological process | positive regulation of antibacterial peptide production |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0006508 | Biological process | proteolysis |
GO_0019538 | Biological process | protein metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0030141 | Cellular component | secretory granule |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005634 | Cellular component | nucleus |
GO_0016811 | Molecular function | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | KLK3 |
Protein name | Kallikrein 3, (Prostate specific antigen), isoform CRA_e (Putative preproPSA-RP2) Kallikrein 3, (Prostate specific antigen), isoform CRA_a (Kallikrein related peptidase 3) Kallikrein 3, (Prostate specific antigen), isoform CRA_d (Kallikrein related peptidase 3) Kallikrein 3, (Prostate specific antigen), isoform CRA_f (Kallikrein related peptidase 3) Prostate specific antigen (Kallikrein A2) (cDNA, FLJ93384, Homo sapiens kallikrein 3, (prostate specific antigen) (KLK3),transcript variant 1, mRNA) Prostate-specific antigen (PSA) (EC 3.4.21.77) (Gamma-seminoprotein) (Seminin) (Kallikrein-3) (P-30 antigen) (Semenogelase) Prostate specific antigen Prostate specific antigen (Kallikrein related peptidase 3) (Prostate-specific antigen variant 1) (Prostate-specific antigen variant 2) Kallikrein related peptidase 3 |
Synonyms | APS hCG_22929 KLNA2 |
Description | FUNCTION: Hydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum. |
Accessions | A0A0B4J1X3 ENST00000595392.5 Q546G3 ENST00000422986.6 M0R1F0 P07288 ENST00000597483.5 M0R1Z7 ENST00000598145.1 M0QZF9 Q8NCW4 ENST00000595952.5 [P07288-3] ENST00000326003.7 [P07288-1] Q7LBD2 ENST00000360617.7 [P07288-2] ENST00000596185.5 ENST00000601503.5 M0R294 ENST00000593997.5 [P07288-5] Q96A30 ENST00000597286.5 M0QX57 |